相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer
Malvin Jefri et al.
BMC CANCER (2015)
Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers
Yi He et al.
CANCER BIOMARKERS (2015)
Refining the treatment of NSCLC according to histological and molecular subtypes
Anish Thomas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Secretome identification of immune cell factors mediating metastatic cell homing
Brian A. Aguado et al.
SCIENTIFIC REPORTS (2015)
Immune Modulation in Cancer with Antibodies
David B. Page et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets
Steven L. Wood et al.
CANCER TREATMENT REVIEWS (2014)
Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer
Ruochuan Sun et al.
MOLECULAR CANCER (2014)
VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer
T. Fleitas et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis
Yida Liao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
Raul Aguirre-Gamboa et al.
PLOS ONE (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
A Novel Classification of Lung Cancer into Molecular Subtypes
Lisandra West et al.
PLOS ONE (2012)
Protein Signature of Lung Cancer Tissues
Michael R. Mehan et al.
PLOS ONE (2012)
Thrombospondin-1: Multiple Paths to Inflammation
Zenaida Lopez-Dee et al.
MEDIATORS OF INFLAMMATION (2011)
Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer
Ina Thoem et al.
CANCER (2010)
Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1
Bee K. Tan et al.
CARDIOVASCULAR RESEARCH (2009)
Microvessel Density and Expression of Thrombospondin-1 in Non-small Cell Lung Cancer and Their Correlation with Clinicopathological Features
Z. J. Chen et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
Thrombospondins function as regulators of angiogenesis
Paul Bornstein
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Thrombospondins in cancer
S. Kazerounian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Structure of thrombospondins
C. B. Carlson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Meta Analysis of Gene Expression Data within and Across Species
Ana C. Fierro et al.
CURRENT GENOMICS (2008)
Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma
Jannie M. Rendtlew Danielsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Interactions between CD47 and thrombospondin reduce inflammation
Laurence Lamy et al.
JOURNAL OF IMMUNOLOGY (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Thrombospondin/CD47 interaction:: A pathway to generate regulatory T cells from human CD4+CD25- T cells in response to inflammation
Philippe Grimbert et al.
JOURNAL OF IMMUNOLOGY (2006)
Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells
F Marteau et al.
BLOOD (2005)
Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis
R Pirinen et al.
HUMAN PATHOLOGY (2005)
The thrombospondins
CAA Josephine et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo
YH Noh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer
M Yamaguchi et al.
LUNG CANCER (2002)
Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice
B Lange-Asschenfeldt et al.
BLOOD (2002)
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
J Lawler
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism
T Hawighorst et al.
EMBO JOURNAL (2001)
Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin
S Goicoechea et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
